Authors
Latest:
Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment ChangesSilvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, conclude by sharing their approaches to evaluating patient satisfaction and expectations when providing care for ulcerative colitis and Crohn's disease, while also touching upon the importance of discussing the potential need for escalating or switching therapies to better manage the underlying disease processes.
Latest:
Key Takeaways on the Evolving COPD Treatment LandscapeThe panel concludes the discussion with key takeaways on the evolving treatment landscape for COPD.
Latest:
Endocrine Case Report: Hip PainThis endocrine case report from Brady Pregerson, MD, features a man in his 40s with a history of T1D presenting with waxing and waning right groin and inner thigh pain. Can you determine the proper diagnosis?
Latest:
How Do I Reduce My Blue Light Intake?An ophthalmologist provides insight into the harms of excessive blue light, and simple consumer resolutions.
Latest:
SUNSHINE and SUNRISE Trials in HSAn expert in dermatology reviews the phase 3 SUNSHINE and SUNRISE trials evaluating the use of secukinumab given in 2-week intervals in patients with HS and shares clinical pearls for managing the condition.
Latest:
Closing RemarksPanelists discuss how their approaches to treating patients with rheumatoid arthritis focus on personalized strategies that prioritize achieving remission while carefully monitoring safety and efficacy outcomes.
Latest:
Addressing Patients' Concerns With BiosimilarsDrs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns to biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Latest:
Impact of Diagnosis Delay on Long Term Lupus OutcomesDrs. Anne E. Winkler and Kristi V. Mizelle discuss the negative long term disease outcomes noted in patients who experience a delay in their lupus diagnosis.
Latest:
Addressing Patients' Concerns With BiosimilarsDrs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns to biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Latest:
Monitoring Treatment Response in Treat-to-Target in CDExperts continue the discussion on treat-to-target in CD, highlighting monitoring treatment response.
Latest:
Untapped Potentials - Exploring Overlooked Therapies for Type 2 DiabetesIn this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.
Latest:
Anticipated Developments in the Field of Plaque PsoriasisMatthew Brunner, MHS, PA-C, DFAAPA, highlights the most anticipated developments in the field of treating patients with plaque psoriasis.
Latest:
How New Therapies Change Discussions Around Screening, Management of MASHIn the final installment in our 5-part video series, our pair of experts in hepatology touch upon how an approval for MASH would impact conversations around screening for asymptomatic patient populations.
Latest:
Concluding ThoughtsA panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
Latest:
Refractory Encephalopathy, Multivitamins and Closing ThoughtsMedical experts share insights on managing refractory hepatic encephalopathy and provide concluding remarks and essential points on the condition.
Latest:
Appropriate Guidance for CRC Screening Age, Role of Advocacy OrganizationsIn part 5 of our 5-part discussion, experts discuss their perspective on appropriate guidance for screening age and the future of CRC advocacy.
Latest:
Long-Term Outcomes for Patients Treated for HypercortisolismThe panel concludes by discussing the long-term outcomes for patients treated for hypercortisolism, emphasizing the need for further studies and data, and sharing their final thoughts on the disease and its future management.
Latest:
GLP-1 Receptor Agonists and Pre-Procedure Planning for EndoscopyWith the growing popularity of GLP-1 receptor agonists, understanding their impact on gastric emptying, bowel motility, and potential implications for endoscopy is essential.
Latest:
Assessing Risk and Safety of JAK InhibitorsPanelists discuss the efficacy and safety data for ritlecitinib and deuruxolitinib in treating alopecia areata, highlighting that ritlecitinib achieved SALT scores of ≤20 in 23% of patients at week 24 compared to 1.6% in the placebo group, while deuruxolitinib showed SALT scores of ≤20 in 42.5% (8mg BID ) and 56.8% (12mg BID) of patients, with treatment-emergent adverse events primarily being mild to moderate, including upper respiratory tract infections and headaches for ritlecitinib, and headache and acne for deuruxolitinib.
Latest:
Exploring Oral Systemic Therapies For Plaque Psoriasis: Efficacy, Safety, and Clinical ConsiderationsLauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.
Latest:
The Future and Resources in HCV CareExpert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
Latest:
Clinical Trial Overview: DMEMatthew Cunningham, MD, FASRS, provides the highlights of the YOSEMITE and RHINE trials for patients with diabetic macular edema (DME).
Latest:
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MDSusan Taylor, MD, and Linda Stein Gold, MD, join The Medical Sisterhood for an intimate conversation on the importance of role models and mentors.
Latest:
Advice for Providers Treating VitiligoDr. Woolery-Lloyd shares her advice for vitiligo providers and tips for helpful communication with patients.
Latest:
Key Takeaways for Ulcerative Colitis ManagementExperts in gastroenterology share take-home messages for the management of ulcerative colitis.
Latest:
Optimizing the Management of TRDAn expert panel shares insight on the future treatment landscape for treatment-resistant depression.
